School of Medicine
Showing 91-100 of 219 Results
Stanford Medicine Professor of Pediatric Hematology/Oncology and Professor, by courtesy, of PathologyOn Partial Leave from 10/01/2021 To 09/30/2022
Current Research and Scholarly InterestsHematology/Oncology, biology, and treatment of bone marrow failure disorders, hereditary coagulation disorders-clinical trials.
Alan M Glaseroff
Adjunct Professor, Medicine - Primary Care and Population Health
BioDr. Alan Glaseroff served as the Director of Workforce Transformation in Primary Care at Stanford from the fall of 2015 until mid-June of 2016, where he was responsible for training the teams for Primary Care 2.0, a radical redesign of primary care underway in 2016. He will be joining the faculty at Stanford's Clinical Excellence Research Center this summer, working with Dr. Arnie Milstein to help develop new models of care. He formerly served as Co-Director of Stanford Coordinated Care, a service for patients with complex chronic illness from 2011 to the end of 2015. Dr. Glaseroff, a member of the Innovation Brain Trust for the UniteHERE Health, currently serves as faculty for the Institute of Healthcare Improvement’s “Better Care, Lower Cost” collaborative and served as a a Clinical Advisor to the PBGH “Intensive Outpatient Care Program” CMMI Innovation Grant that completes in June 2015. He served on the NCQA Patient-Centered Medical Home Advisory Committee 2009-2010, and the “Let’s Get Healthy California” expert task force in 2012,. Dr. Glaseroff was named the California Family Physician of the Year for 2009.
Dr. Glaseroff’s interests focus on the intersection of the meaning of patient-centered team care, patient activation, and the key role of self-management within the context of chronic conditions.
The Coordinated Care clinic is an exclusive benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions.
Please complete the Coordinated Care self-assessment to determine eligibility based on health condition(s) and health insurance: https://stanfordmedicine.qualtrics.com/SE/?SID=SV_2siBNrfJ8zmn3GB
Clinical Associate Professor, Pediatrics - Neonatal and Developmental Medicine
Current Research and Scholarly InterestsNeonatal Endocrinology
Jeffrey S. Glenn, M.D., Ph.D.
Joseph D. Grant Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsDr. Glenn's primary interest is in molecular virology, with a strong emphasis on translating this knowledge into novel antiviral therapies. Other interests include exploitation of hepatic stem cells, engineered human liver tissues, liver cancer, and new biodefense antiviral strategies.
Ira D Glick
Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsSchizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.
Professor of Radiology (Radiological Sciences Lab) and, by courtesy, of Psychology and of Electrical Engineering
Current Research and Scholarly InterestsMy present research is devoted to the advancement of functional magnetic resonance imaging sciences for applications in basic understanding of the brain in health and disease. We collaborate closely with departmental clinicians and with others in the school of medicine, humanities, and the engineering sciences.
Anna L Gloyn
Professor of Pediatrics (Endocrinology) and, by courtesy, of Genetics
Current Research and Scholarly InterestsAnna's current research projects are focused on the translation of genetic association signals for type 2 diabetes and glycaemic traits into cellular and molecular mechanisms for beta-cell dysfunction and diabetes. Her group uses a variety of complementary approaches, including human genetics, functional genomics, physiology and islet-biology to dissect out the molecular mechanisms driving disease pathogenesis.